Quest Diagnostics Incorporated (NYSE: DGX) to reaffirm FY10 outlook at the Lazard Capital ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE